Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (0)
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Ameet Sarpatwari, J.D., Ph.D.
Concepts (324)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
Abortifacient Agents, Steroidal
Abortion, Induced
Abortion, Legal
Acute Kidney Injury
Adenosine Monophosphate
Adjuvants, Anesthesia
Adolescent
Adult
Adverse Drug Reaction Reporting Systems
Advisory Committees
Age Factors
Aged
Aged, 80 and over
Alanine
Alleles
Analgesics, Opioid
Anemia
Anemia, Sickle Cell
Angiotensin Receptor Antagonists
Antibodies, Monoclonal
Anticoagulants
Anticonvulsants
Antihypertensive Agents
Antimalarials
Antineoplastic Agents
Antiprotozoal Agents
Antirheumatic Agents
Antitubercular Agents
Antiviral Agents
Anxiety Disorders
Artemisinins
Artificial Intelligence
Atrial Fibrillation
Attitude of Health Personnel
Australia
Behavior Therapy
Benzoates
Benzodiazepines
Bioethical Issues
Biological Products
Biomedical Research
Blood Platelets
Canada
Carcinoma, Non-Small-Cell Lung
Cardiovascular Diseases
Case-Control Studies
Cell Death
Child
Cholic Acid
Chondroitinsulfatases
Chronic Disease
Citalopram
Civil Rights
Clinical Trials as Topic
Clinical Trials, Phase I as Topic
Clinical Trials, Phase III as Topic
Cohort Studies
Commerce
Communication
Compassionate Use Trials
Computer Simulation
Confidentiality
Conflict of Interest
Congresses as Topic
Consumer Product Safety
Coronavirus Infections
Cost Control
Cost Savings
Cost-Benefit Analysis
Costs and Cost Analysis
Cross-Sectional Studies
Cytokines
Data Interpretation, Statistical
Databases as Topic
Databases, Factual
Dementia
Dermatologic Agents
Device Approval
Diabetes Mellitus
Diabetes Mellitus, Type 2
Diabetic Ketoacidosis
Diffusion of Innovation
Disclosure
Disease Outbreaks
Disease Susceptibility
Disinfection
DNA-Binding Proteins
Drug and Narcotic Control
Drug Approval
Drug Combinations
Drug Costs
Drug Design
Drug Discovery
Drug Evaluation
Drug Industry
Drug Labeling
Drug Prescriptions
Drug Recalls
Drug Substitution
Drug Utilization
Drugs, Generic
Drugs, Investigational
Duodenoscopes
Economic Competition
Economics, Pharmaceutical
Electrocardiography
Electronic Health Records
Employee Retirement Income Security Act
Epidemiologic Methods
Epoetin Alfa
Equipment Contamination
Erythropoietin
Ethanolamines
Europe
European Union
Federal Government
Female
Fentanyl
Fever
Financial Management
Financing, Government
Fish Oils
Fluorenes
Follow-Up Studies
Forecasting
Fractures, Bone
Gastrointestinal Stromal Tumors
Gatekeeping
Genetic Predisposition to Disease
Germany
Government Agencies
Government Regulation
Health Care Costs
Health Care Reform
Health Expenditures
Health Insurance Portability and Accountability Act
Health Knowledge, Attitudes, Practice
Health Planning
Health Policy
Health Promotion
Health Services Accessibility
Health Services Needs and Demand
Health Services Research
Health Surveys
Helicobacter Infections
Helicobacter pylori
Hematinics
Hemoglobins
Hemorrhage
Hemorrhagic Disorders
Hemorrhagic Fever, Ebola
Hepatitis C
History, 20th Century
History, 21st Century
HIV Infections
Hospitals
Hospitals, Pediatric
Humans
Hydrazines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hydroxyzine
Hypertension, Pulmonary
Hypoglycemic Agents
Immunization, Secondary
Immunologic Factors
Incidence
Indium Radioisotopes
Information Dissemination
Informed Consent
Insulin
Insurance Claim Review
Insurance, Health
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Intellectual Property
Intention
Investments
Isotretinoin
Judicial Role
Jurisprudence
Lawyers
Legislation as Topic
Legislation, Drug
Length of Stay
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Life Style
Liver Function Tests
Logistic Models
Long QT Syndrome
Longitudinal Studies
Lower Extremity
Lung Neoplasms
Male
Marketing
Marketing of Health Services
Medicaid
Medical Oncology
Medical Records
Medicare
Medicare Part C
Medicare Part D
Medication Adherence
Menstruation-Inducing Agents
Meta-Analysis as Topic
Middle Aged
Mifepristone
Minority Groups
Models, Economic
Multiple Myeloma
National Institute of Allergy and Infectious Diseases (U.S.)
National Institutes of Health (U.S.)
Neglected Diseases
Negotiating
Neoplasms
Neuroprotective Agents
New York
Odds Ratio
Off-Label Use
Opioid-Related Disorders
Organizations, Nonprofit
Orphan Drug Production
Pandemics
Patents as Topic
Patient Acceptance of Health Care
Patient Education as Topic
Patient Participation
Patient Preference
Patient Protection and Affordable Care Act
Perception
Pharmaceutical Preparations
Pharmaceutical Services
Pharmacies
Pharmacists
Phenylcarbamates
Phenylpropionates
Phosphorylcholine
Physicians
Platelet Count
Pneumonia, Viral
Policy
Policy Making
Politics
Polymorphism, Single Nucleotide
Pregnancy
Preoperative Care
Prescription Drugs
Prescription Fees
Privacy
Private Sector
Product Surveillance, Postmarketing
Professional Role
Prognosis
Program Development
Propensity Score
Public Health
Public Sector
Purpura, Thrombocytopenic, Idiopathic
Pyrazoles
Pyridazines
Qualitative Research
Quality Control
Quality of Life
Radionuclide Imaging
Randomized Controlled Trials as Topic
Rare Diseases
Receptors, Cytokine
Receptors, Fc
Recombinant Fusion Proteins
Recombinant Proteins
Registries
Reproductive Rights
Research
Research Design
Research Support as Topic
Retrospective Studies
Rheumatic Diseases
Risk
Risk Assessment
Risk Factors
Risk Management
Risk Reduction Behavior
RNA, Messenger
Salaries and Fringe Benefits
Sample Size
Secondary Prevention
Self Care
Sertraline
Sex Factors
Social Class
Social Control, Formal
Socioeconomic Factors
Sodium Oxybate
Spleen
Splenectomy
State Government
State Health Plans
State Medicine
Supreme Court Decisions
Survival Rate
Tablets
Teratogens
Thalidomide
Therapeutic Equivalency
Therapies, Investigational
Thiazolidinediones
Thrombocytopenia
Thromboembolism
Thrombopoietin
Time Factors
Torsades de Pointes
Treatment Outcome
Tumor Necrosis Factor-alpha
Uncertainty
United States
United States Dept. of Health and Human Services
United States Federal Trade Commission
United States Food and Drug Administration
Universities
Urinary Tract Infections
Vaccines
Venous Thromboembolism
Vigabatrin
Warfarin
Young Adult
Sarpatwari's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (324)
Derived automatically from this person's publications.
Prescription Drugs
Drug Industry
Drugs, Generic
Drug Costs
Drug Approval
Explore
_
Co-Authors (32)
People in Profiles who have published with this person.
Sacks, Chana
Curfman, Gregory
Gagne, Joshua
Avorn, Jerome
Rome, Benjamin
Explore
_
Similar People (60)
People who share similar concepts with this person.
Frank, Richard
Gagne, Joshua
Avorn, Jerome
Feldman, William
Rome, Benjamin
Explore
_
Same Department
People in same department with this person.
Baig, Mirza
Dashevsky, Inna
Iyer, Geetha
Lane, Kimberly
Shinde, Mayura
Explore
_